-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNIC ANNOUNCES VIDOFLUDIMUS CALCIUM REDUCED RISK OF DISABILITY WORSENING BY 30% IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS PATIENTS FROM PHASE 2 CALLIPER TRIAL

Reuters·04/30/2025 11:30:11

Please log in to view news